Paper7624312
Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells.
Rivière I and 2 others. Proc Natl Acad Sci U S A, 1995. Cited by 320 papers, by iCite.
Cite this record
ConductScience Library. Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells. Papers, record 7624312. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7624312
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effects of retroviral vector design on expression of human adenosine deaminase in murine bone marrow transplant recipients engrafted with genetically modified cells.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenosine Deaminase | Major topic |
| Bone Marrow Transplantation | Major topic |
| Genetic Vectors | Major topic |
| Moloney murine leukemia virus | Major topic |
| Transduction, Genetic | Major topic |
| Animals | |
| Hematopoietic Stem Cells | |
| Humans | |
| Mice | |
| Mice, Inbred C57BL | |
| Regulatory Sequences, Nucleic Acid | |
| Time Factors |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| HL37569 | NHLBI NIH HHS | United States | R01HL037569 | PubMed and NIH |
Source NIH RePORTER
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3418785 | Development of retrovirus vectors useful for expressing genes in cultured murine embryonal cells and hematopoietic cells in vivo. | J Virol | 1988 | https://conductscience.org/library/papers/3418785 | PubMed |
| 2 | 3413107 | Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. | Proc Natl Acad Sci U S A | 1988 | https://conductscience.org/library/papers/3413107 | PubMed |
| 3 | 1967217 | Serial transplantation of methotrexate-resistant bone marrow: protection of murine recipients from drug toxicity by progeny of transduced stem cells. | Blood | 1990 | https://conductscience.org/library/papers/1967217 | PubMed |
| 4 | 2296599 | Expression of human adenosine deaminase in mice reconstituted with retrovirus-transduced hematopoietic stem cells. | Proc Natl Acad Sci U S A | 1990 | https://conductscience.org/library/papers/2296599 | PubMed |
| 5 | 2328323 | Expression of human adenosine deaminase in mice after transplantation of genetically-modified bone marrow. | Blood | 1990 | https://conductscience.org/library/papers/2328323 | PubMed |
| 6 | 2337676 | Human adenosine deaminase expression in mice. | Blood | 1990 | https://conductscience.org/library/papers/2337676 | PubMed |
| 7 | 1974914 | Expression of human adenosine deaminase in mice transplanted with hemopoietic stem cells infected with amphotropic retroviruses. | J Exp Med | 1990 | https://conductscience.org/library/papers/1974914 | PubMed |
| 8 | 2081183 | Long-term expression of human adenosine deaminase in mice after transplantation of bone marrow infected with amphotropic retroviral vectors. | Hum Gene Ther | 1990 | https://conductscience.org/library/papers/2081183 | PubMed |
| 9 | 2070069 | Retroviral gene transfer of human adenosine deaminase in murine hematopoietic cells: effect of selectable marker sequences on long-term expression. | Blood | 1991 | https://conductscience.org/library/papers/2070069 | PubMed |
| 10 | 1863641 | Retroviral vectors related to the myeloproliferative sarcoma virus allow efficient expression in hematopoietic stem and precursor cell lines, but retroviral infection is reduced in more primitive cells. | Hum Gene Ther | 1991 | https://conductscience.org/library/papers/1863641 | PubMed |
| 11 | 1962213 | Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. | Science | 1991 | https://conductscience.org/library/papers/1962213 | PubMed |
| 12 | 1502175 | Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirus-infected bone-marrow cells. | Proc Natl Acad Sci U S A | 1992 | https://conductscience.org/library/papers/1502175 | PubMed |
| 13 | 1454816 | Efficient transfer and sustained high expression of the human glucocerebrosidase gene in mice and their functional macrophages following transplantation of bone marrow transduced by a retroviral vector. | Proc Natl Acad Sci U S A | 1992 | https://conductscience.org/library/papers/1454816 | PubMed |
| 14 | 7678068 | Factors affecting the transduction of pluripotent hematopoietic stem cells: long-term expression of a human adenosine deaminase gene in mice. | Blood | 1993 | https://conductscience.org/library/papers/7678068 | PubMed |
| 15 | 8097319 | Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. | Proc Natl Acad Sci U S A | 1993 | https://conductscience.org/library/papers/8097319 | PubMed |
| 16 | 7691243 | Long-term in vivo expression of a murine adenosine deaminase gene in rhesus monkey hematopoietic cells of multiple lineages after retroviral mediated gene transfer into CD34+ bone marrow cells. | Blood | 1993 | https://conductscience.org/library/papers/7691243 | PubMed |
| 17 | 8146155 | Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/8146155 | PubMed |
| 18 | 1195397 | Detection of specific sequences among DNA fragments separated by gel electrophoresis. | J Mol Biol | 1975 | https://conductscience.org/library/papers/1195397 | PubMed |
| 19 | 597858 | Complete nucleotide sequence of the 5' noncoding region of human alpha-and beta-globin mRNA. | Cell | 1977 | https://conductscience.org/library/papers/597858 | PubMed |
| 20 | 6678608 | Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. | Cell | 1983 | https://conductscience.org/library/papers/6678608 | PubMed |
Cited by150
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 320 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42722692 | Cancer-driver-agnostic targeting of amplified surface proteins identifies MPZL1 for selective CAR-T cell therapy. | Nat Commun | 2026 | https://conductscience.org/library/papers/42722692 | PubMed |
| 42718816 | Control of breast cancer patient-derived xenografts by CD70-targeted HIT-CAR T cells. | Front Immunol | 2026 | https://conductscience.org/library/papers/42718816 | PubMed |
| 42174275 | Tumor irradiation promotes antigen dressing of dendritic cells to enhance CAR T cell persistence and efficacy in lung metastases. | Nat Cancer | 2026 | https://conductscience.org/library/papers/42174275 | PubMed |
| 42167810 | Membrane-bound TRAIL-armoring augments CAR-T cells in mesothelin-positive solid malignancies. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42167810 | PubMed |
| 42061408 | Engineering functionality-optimized fully human B7-H3 CAR T cells for enhanced solid tumor therapy. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/42061408 | PubMed |
| 41981294 | Targeted cellular micropharmacies deliver therapeutic agents to the brain. | EMBO Mol Med | 2026 | https://conductscience.org/library/papers/41981294 | PubMed |
| 41695488 | Modeling immunotherapies in live 3D human cancer tissue bioreactors. | Theranostics | 2026 | https://conductscience.org/library/papers/41695488 | PubMed |
| 41542454 | Engineering Functionality Optimized fully human B7-H3 CAR T Cells for Enhanced Solid Tumor Therapy. | bioRxiv | 2026 | https://conductscience.org/library/papers/41542454 | PubMed |
| 41520178 | IL-18 metabolically reprograms CAR-expressing natural killer T cells and enhances their antitumor activity. | Mol Ther | 2026 | https://conductscience.org/library/papers/41520178 | PubMed |
| 41495526 | CAR-adapted PIK3CD base editing enhances T cell anti-tumor potency. | Nat Cancer | 2026 | https://conductscience.org/library/papers/41495526 | PubMed |
| 41279666 | Site-specific genome engineering of primary human natural killer cells for programmable anti-tumor function. | bioRxiv | 2025 | https://conductscience.org/library/papers/41279666 | PubMed |
| 41057651 | Large-scale generation of iNK and CAR-iNK cells from CD34+ haematopoietic stem and progenitor cells for adoptive immunotherapy. | Nat Biomed Eng | 2026 | https://conductscience.org/library/papers/41057651 | PubMed |
| 40921629 | CD33KO-CD33-mesothelin Loop CAR design avoids fratricide and improves efficacy of iNK cells against acute myeloid leukemia. | J Immunother Cancer | 2025 | https://conductscience.org/library/papers/40921629 | PubMed |
| 40696154 | CAR-engineered lymphocyte persistence is governed by a FAS ligand-FAS autoregulatory circuit. | Nat Cancer | 2025 | https://conductscience.org/library/papers/40696154 | PubMed |
| 40390054 | Engineered CRO-CD7 CAR-NK cells derived from pluripotent stem cells avoid fratricide and efficiently suppress human T-cell malignancies. | J Hematol Oncol | 2025 | https://conductscience.org/library/papers/40390054 | PubMed |
| 40207929 | Persistence of CMV-specific anti-HIV CAR T cells after adoptive immunotherapy. | J Virol | 2025 | https://conductscience.org/library/papers/40207929 | PubMed |
| 39973814 | A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell Function. | Cancer Res Commun | 2025 | https://conductscience.org/library/papers/39973814 | PubMed |
| 39715901 | Leucine zipper-based immunomagnetic purification of CAR T cells displaying multiple receptors. | Nat Biomed Eng | 2024 | https://conductscience.org/library/papers/39715901 | PubMed |
| 39308793 | TYRP1 directed CAR T cells control tumor progression in preclinical melanoma models. | Mol Ther Oncol | 2024 | https://conductscience.org/library/papers/39308793 | PubMed |
| 38981470 | Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapies. | Cell Stem Cell | 2024 | https://conductscience.org/library/papers/38981470 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ADA | 100 | PubTator's text mining | https://conductscience.org/library/genes/100 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7624312
GET https://conductscience.org/api/papers/v1/7624312/references?page=2